statistiche ricercatore

Continente	#
NA - Nord America	889
EU - Europa	645
AS - Asia	396
SA - Sud America	104
AF - Africa	6
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.041

Nazione	#
US - Stati Uniti d'America	879
RU - Federazione Russa	182
CN - Cina	127
IE - Irlanda	114
SG - Singapore	102
GB - Regno Unito	95
BR - Brasile	86
IT - Italia	74
VN - Vietnam	69
SE - Svezia	52
HK - Hong Kong	32
UA - Ucraina	29
DE - Germania	24
FR - Francia	20
FI - Finlandia	16
KR - Corea	14
IN - India	12
TR - Turchia	9
AR - Argentina	7
AT - Austria	7
CA - Canada	7
BE - Belgio	6
NL - Olanda	6
CZ - Repubblica Ceca	5
BD - Bangladesh	4
JP - Giappone	4
KZ - Kazakistan	4
AZ - Azerbaigian	3
EC - Ecuador	3
EG - Egitto	3
ID - Indonesia	3
PL - Polonia	3
PY - Paraguay	3
UZ - Uzbekistan	3
CH - Svizzera	2
CO - Colombia	2
ES - Italia	2
LT - Lituania	2
MX - Messico	2
PT - Portogallo	2
SA - Arabia Saudita	2
ZA - Sudafrica	2
A2 - ???statistics.table.value.countryCode.A2???	1
AL - Albania	1
BA - Bosnia-Erzegovina	1
BO - Bolivia	1
CR - Costa Rica	1
GR - Grecia	1
IL - Israele	1
IR - Iran	1
MA - Marocco	1
NO - Norvegia	1
NP - Nepal	1
PE - Perù	1
PK - Pakistan	1
TH - Thailandia	1
TL - Timor Orientale	1
TM - Turkmenistan	1
TW - Taiwan	1
UY - Uruguay	1
Totale	2.041

Nome	#
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections	261
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform	242
Profiling of flavonol derivatives for the development of antitrypanosomatidic drugs	239
Chroman-4-one derivatives targeting pteridine reductase 1 and showing anti-parasitic activity	236
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery	216
Development of flavonol and flavanone derivatives as anti-trypanosomatidic drugs	188
High-resolution crystal structure of Trypanosoma brucei pteridine reductase 1 in complex with an innovative tricyclic-based inhibitor	181
Structural Insights into the Development of Cycloguanil Derivatives as Trypanosoma brucei Pteridine-Reductase-1 Inhibitors	165
Repurposing the Trypanosomatidic GSK Kinetobox for the Inhibition of Parasitic Pteridine and Dihydrofolate Reductases	141
Multitarget, selective compound design yields potent inhibitors of a Kinetoplastid Pteridine Reductase 1	133
The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents	97
Totale	2.099

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	132	0	0	0	0	0	19	9	25	11	20	9	39
2021/2022	150	3	22	17	19	9	4	6	10	7	9	15	29
2022/2023	152	8	9	26	11	16	38	3	14	18	2	5	2
2023/2024	189	9	3	17	14	4	50	61	3	2	6	0	20
2024/2025	324	12	15	30	11	40	28	8	16	35	11	38	80
2025/2026	672	55	130	129	169	187	2	0	0	0	0	0	0
Totale													2.099